LFG
CTSO icon

Larson Financial Group’s Cytosorbents Corp CTSO Stock Holding History

Larson Financial Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9
Closed – – 1085
2021
Q3 		$0 Hold
9
– – ﹤0.01% 892
2021
Q2 		$0 Hold
9
– – ﹤0.01% 835
2021
Q1 		$0 Hold
9
– – ﹤0.01% 841
2020
Q4 		$0 Hold
9
– – ﹤0.01% 768
2020
Q3 		$0 Hold
9
– – ﹤0.01% 743
2020
Q2 		$0 Sell
9
-28
-76% -$257 ﹤0.01% 693
2020
Q1 		$0 Hold
37
– – ﹤0.01% 555
2019
Q4 		$0 Hold
37
– – ﹤0.01% 590
2019
Q3 		$0 Hold
37
– – ﹤0.01% 552
2019
Q2 		$0 Hold
37
– – ﹤0.01% 505
2019
Q1 		$0 Hold
37
– – ﹤0.01% 501
2018
Q4 		$0 Buy
+37
New +$367 ﹤0.01% 480

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Larson Financial Group's CTSO Position: Q4 2021 in Review

Larson Financial Group sold out of Cytosorbents Corp (CTSO) in Q4 2021, closing a stake of 9 shares.

Larson Financial Group first reported a position in CTSO in Q4 2018 and held it in 12 quarters. The position peaked at $0 in Q3 2021. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

  • Larson Financial Group reported no remaining Cytosorbents Corp position as of Q4 2021 after selling out during the quarter.
  • Larson Financial Group sold 9 Cytosorbents Corp shares in Q4 2021.
  • Larson Financial Group first reported a position in Cytosorbents Corp in Q4 2018 and held it in 12 quarters.
  • Larson Financial Group's Cytosorbents Corp position peaked at $0 in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2021.

Based on Larson Financial Group's 13F filing for Q4 2021, filed 3 Feb 2022.